Search results for: Adrian Towse
Filter search results
Differential Pricing – A Win-Win Solution?
2 March 2011
…equity in access to medicines across the EU. Download Garau, M., Towse, A. and Danzon, P. (2011) Pharmaceutical pricing in Europe: Is differential pricing a win-win solution? Occasional Paper 11/01. …
New: Antimicrobial Drug Incentives
6 April 2011
…as seen in the 2010 reaction to evidence on the origins of NDM-1. Download Towse, A. and Sharma, P. (2011) Incentives for R&D for new antimicrobial dugs. OHE Research Paper 11/02. …
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
…Danzon, P., Mulcahy, A.W. and Towse, A. (2011) Pharmaceutical pricing in emerging markets: Effects of income, competition and procurement. NBER Working Paper No. 17174. Cambridge, MA: National Bureau of Economic…
New: Operationalising Value Based Pricing
11 August 2011
…is examined; both these and proposals for the UK are placed in the context of the taxonomy. Download Sussex, J., Towse, A. and Devlin, N. (2011) Operationalising Value Based Pricing…
Evidence on Valued Based Pricing and Reimbursement Schemes
30 September 2011
…for pharmaceuticals. In particular, a better understanding is needed about whether and how transaction costs may affect the implementation of the schemes. Download Puig-Pieró, R., Merstre-Ferrandiz, J., Sussex, J. and Towse,…
New: Pay-for-Performance for Drugs and Incentives for Innovation
27 February 2012
…schemes, providing examples; discuss the benefits and weaknesses of such schemes; and consider their value as an incentive for innovation. Download Towse, A., Garrison, L. and Puig-Peiró, R. The use…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…at launch, review would be by a diagnostics-dedicated committee using VBP principles. Download Garau, M., Towse, A., Garrison, L., Housman L. and Ossa, D. Can and should value based pricing…
Spotlight on OHE: Recent Awards, Publications and Presentations
12 September 2012
…Valuing health at the end of life: An exploratory preference elicitation study. OHE Research Paper 11/06. London: Office of Health Economics. [2] Puig-Peiró, R., Mestre-Ferrandiz, J., MacDonald, F. and Towse,…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
…use. These are essential both to encouraging R&D and ensuring that patients have the earliest access possible to life-changing therapies’. Contact: Jorge Mestre-Ferrandiz Download Mestre-Ferrandiz, J., Sussex, J. and Towse,…